Brief: Medacta H1 Adjusted EBIT EUR 62.4 Million
Sep 08 (Reuters) - Medacta H1 adjusted EBITDA EUR 98.8 million. H1 adjusted EBITDA margin 29.6% H1 gross margin 68.3% H1 adjusted free cash flow EUR 73 million outlook FY revenue growth 16-18% outlook FY adjusted EBITDA margin 28%
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million